Cargando…

Risk Factors for Hepatitis C Virus Reinfection After Sustained Virologic Response in Patients Coinfected With HIV

BACKGROUND. Highly effective hepatitis C virus (HCV) therapies have spurred a scale-up of treatment to populations at greater risk of reinfection after sustained virologic response (SVR). Reinfection may be higher in HIV–HCV coinfection, but prior studies have considered small selected populations....

Descripción completa

Detalles Bibliográficos
Autores principales:	Young, Jim, Rossi, Carmine, Gill, John, Walmsley, Sharon, Cooper, Curtis, Cox, Joseph, Martel-Laferriere, Valerie, Conway, Brian, Pick, Neora, Vachon, Marie-Louise, Klein, Marina B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399935/ https://www.ncbi.nlm.nih.gov/pubmed/28199495 http://dx.doi.org/10.1093/cid/cix126

Ejemplares similares

Direct-Acting Antiviral Treatment Failure Among Hepatitis C and HIV–Coinfected Patients in Clinical Care
por: Rossi, Carmine, et al.
Publicado: (2019)

Impact of Hepatitis C Virus Cure on Depressive Symptoms in the Human Immunodeficiency Virus-Hepatitis C Virus Coinfected Population in Canada
por: Marathe, Gayatri, et al.
Publicado: (2022)

Tobacco Smoking Is Not Associated With Accelerated Liver Disease in Human Immunodeficiency Virus-Hepatitis C Coinfection: A Longitudinal Cohort Analysis
por: Costiniuk, Cecilia T., et al.
Publicado: (2016)

How Generalizable Are the Results From Trials of Direct Antiviral Agents to People Coinfected With HIV/HCV in the Real World?
por: Saeed, Sahar, et al.
Publicado: (2016)

Trends in cause-specific mortality in HIV–hepatitis C coinfection following hepatitis C treatment scale-up
por: Kronfli, Nadine, et al.
Publicado: (2019)

Frequent injection cocaine use increases the risk of renal impairment among hepatitis C and HIV coinfected patients
por: Rossi, Carmine, et al.
Publicado: (2016)

Gender differences in clinical, immunological, and virological outcomes in highly active antiretroviral-treated HIV–HCV coinfected patients
por: Emery, Joel, et al.
Publicado: (2010)

Progression of Liver Fibrosis and Modern Combination Antiretroviral Therapy Regimens in HIV-Hepatitis C–Coinfected Persons
por: Brunet, Laurence, et al.
Publicado: (2016)

Estimating an individual-level deprivation index for HIV/HCV coinfected persons in Canada
por: Palayew, Adam, et al.
Publicado: (2021)

Hepatitis C virus cure does not impact kidney function decline in HIV co-infected patients
por: Rossi, Carmine, et al.
Publicado: (2018)

HIV virological rebounds but not blips predict liver fibrosis progression in antiretroviral-treated HIV/hepatitis C virus-coinfected patients
por: Cooper, C, et al.
Publicado: (2015)

Virological Outcomes After Switching to Abacavir/Lamivudine/Dolutegravir Combined with Adherence Support in People Living with HIV with Poor Adherence: A Phase IV, Multicentre Randomized Prospective Open Label Study (TriiADD-CTN 286)
por: Klein, Marina B, et al.
Publicado: (2022)

Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR Study
por: Liu, Chen-Hua, et al.
Publicado: (2022)

Cocaine/crack use is not associated with fibrosis progression measured by AST-to-Platelet Ratio Index in HIV-HCV co-infected patients: a cohort study
por: Martel-Laferrière, Valérie, et al.
Publicado: (2017)

Hepatic Fibrosis Progression in HIV-Hepatitis C Virus Co-Infection – The Effect of Sex on Risk of Significant Fibrosis Measured by Aspartate-to-Platelet Ratio Index
por: Rollet-Kurhajec, Kathleen C., et al.
Publicado: (2015)

Eliminating Structural Barriers: The Impact of Unrestricted Access on Hepatitis C Treatment Uptake Among People Living With Human Immunodeficiency Virus
por: Saeed, Sahar, et al.
Publicado: (2020)

The Effect of Hepatitis C Virologic Clearance on Cardiovascular Disease Biomarkers in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection
por: Chew, Kara W., et al.
Publicado: (2014)

Previous incarceration impacts access to hepatitis C virus (HCV) treatment among HIV‐HCV co‐infected patients in Canada
por: Kronfli, Nadine, et al.
Publicado: (2018)

Predicting the presence of depressive symptoms in the HIV-HCV co-infected population in Canada using supervised machine learning
por: Marathe, Gayatri, et al.
Publicado: (2022)

Evaluation of Safety and Effectiveness of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Switch Followed by Ledipasvir/Sofosbuvir HCV Therapy in HIV–HCV Coinfection
por: Doyle, Mary-Anne, et al.
Publicado: (2019)

Responder Interferon λ Genotypes Are Associated With Higher Risk of Liver Fibrosis in HIV–Hepatitis C Virus Coinfection
por: Moqueet, Nasheed, et al.
Publicado: (2016)

Disparities in direct acting antivirals uptake in HIV‐hepatitis C co‐infected populations in Canada
por: Saeed, Sahar, et al.
Publicado: (2017)

Sustained Virologic Suppression With Dolutegravir/Lamivudine in a Test-and-Treat Setting Through 48 Weeks
por: Rolle, Charlotte-Paige, et al.
Publicado: (2023)

Marijuana Smoking Does Not Accelerate Progression of Liver Disease in HIV–Hepatitis C Coinfection: A Longitudinal Cohort Analysis
por: Brunet, Laurence, et al.
Publicado: (2013)

Factors affecting antiretroviral pharmacokinetics in HIV-infected women with virologic suppression on combination antiretroviral therapy: a cross-sectional study
por: Loutfy, Mona Rafik, et al.
Publicado: (2013)

Durable Sustained Virologic Response After Oral Directly Acting Antiviral Therapy Despite Immunosuppressive Treatment
por: Hahn, Katherine J., et al.
Publicado: (2015)

Clinical Features and Treatment Outcomes of Pulmonary Mycobacterium avium-intracellulare Complex With and Without Coinfections
por: Wang, Grace, et al.
Publicado: (2022)

Clinical Spectrum of Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Protection From Symptomatic Reinfection
por: Maier, Hannah E, et al.
Publicado: (2021)

Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection Associates With Unstable Housing and Occurs in the Presence of Antibodies
por: Bean, David J, et al.
Publicado: (2021)

Screening for Sexually Transmitted Infections During Hepatitis C Treatment to Predict Reinfection Among People With HIV
por: Hill, Lucas A, et al.
Publicado: (2020)

Impact of an Electronic Medical Record Best Practice Alert on Expedited Partner Therapy for Chlamydia Infection and Reinfection
por: Willis, Sarah J, et al.
Publicado: (2021)

Distinguishing Severe Acute Respiratory Syndrome Coronavirus 2 Persistence and Reinfection: A Retrospective Cohort Study
por: Turbett, Sarah E, et al.
Publicado: (2022)

Prevalence of Intestinal Helminth Coinfection in Drug-Resistant Tuberculosis in Uganda
por: Baluku, Joseph Baruch, et al.
Publicado: (2022)

Coinfection With Severe Fever With Thrombocytopenia Syndrome and Scrub Typhus in Korea
por: Chatterjee, Shilpa, et al.
Publicado: (2023)

The Impact of Neisseria gonorrhoeae Mono- and Coinfection on Adverse Pregnancy Outcomes
por: Taylor, Brandie DePaoli, et al.
Publicado: (2023)

Reduced Odds of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection After Vaccination Among New York City Adults, July 2021–November 2021
por: Levin-Rector, Alison, et al.
Publicado: (2022)

Virological Mechanisms in the Coinfection between HIV and HCV
por: Liberto, Maria Carla, et al.
Publicado: (2015)

Virological and Serological Assessment of US Army Trainees Isolated for Coronavirus Disease 2019
por: Hakre, Shilpa, et al.
Publicado: (2022)

Prevalence of Antibiotic Tolerance and Risk for Reinfection Among Escherichia coli Bloodstream Isolates: A Prospective Cohort Study
por: Lazarovits, Gilad, et al.
Publicado: (2022)

Post-COVID-19 Syndrome 2 Years After the First Wave: The Role of Humoral Response, Vaccination and Reinfection
por: Peghin, Maddalena, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_m2k75nenmf343ce9t6e9pralkp